FindTrial
Sign In

Development and application of intelligent monitoring technology for early screening of Alzheimer's disease and progress of cognitive impairment

Development and application of intelligent monitoring technology for early screening of Alzheimer's disease and progress of cognitive impairment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068808
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

subject cognitive decline group:Nil
mild cognitive impairment group:Nil
early AD group:Nil
normal elderly group:No

Sponsors

Tongji Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 55-85 years old Meet the clinical diagnostic criteria for AD dementia (2011 NIA-AA) Meet the clinical diagnostic criteria of AD-derived MCI Meet the clinical diagnostic criteria of SCD Normal elderly

Exclusion criteria

Exclusion criteria: 1. Those who have severe vision, hearing, aphasia and other physical diseases and cannot successfully complete the neuropsychological test; 2. Have other serious neurological or psychiatric disease history (such as stroke, Parkinson's disease, major depression, schizophrenia, etc.), serious cardiovascular disease, thyroid disease, vitamin B12 deficiency or drug abuse history or evidence; 3. Structural magnetic resonance or CT showed new lesions or space-occupying lesions.

Design outcomes

Primary

MeasureTime frame
Cognitive psychological scale;MRI;EEG;Blood test index;—

Countries

China

Contacts

Public ContactLi Yunxia

Tongji Hospital Affiliated to Tongji University

Doctorliyunxia@163.com+86 136 3637 0312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026